Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients

Table 3

Univariate prognostic factor analysis.

Factors		3 y-FFS (%)		3 y-0S (%)
Age (years)
<60	156	90.5	0.726	95.1	0.812
60-69	58	96.4		95
≥70	17	90.9		90
T-category
≤T2	149	92.3	0.05	100	0.497
>T3	82	64.3		80
N-category
N+	39	94.1	0.465	100	0.054
N-	192	75.9		89.1
Stage
I-IIIB	184	88.4	0.043	97.4	0.693
IIIC-IV	47	0		91.7
Tumor grade
G1-2	116	90	0.505	95.8	0.054
G3	115	90.6		100
Myometrial invasion
<50%	63	93.6	0.652	100	0.221
>50%	82	91.4		94.9
Parametrium invasion
Yes	9	87.4	0.947	96.2	0.532
No	107	100		100
Cervical junction involvement
Yes	96	92.2	0.384	98	0.055
No	39	85.2		88.2

FFS: failure-free survival; OS: overall survival.